AOD-9604

AOD-9604 is a modified fragment of human growth hormone (176-191) studied in metabolic research. It ships lyophilized and is reconstituted with bacteriostatic water before use.

Key research interest

AOD-9604 is studied across several research directions. The points below summarize what the published literature investigates — they describe research interest only, not outcomes, benefits, or any human-use claim.

• Studied for stimulation of lipolysis (fat breakdown) in adipose tissue
• Researched for inhibition of lipogenesis (new fat formation)
• Investigated for fat metabolism without affecting blood glucose
• Examined for absence of IGF-1-mediated growth effects
• Studied for cartilage and tissue-repair markers in preclinical models

Mechanism of action

A synthetic analog of the C-terminal (176-191) region of human growth hormone, studied for mimicking GH’s lipolytic activity by stimulating fat breakdown and inhibiting lipogenesis. Research indicates it acts on fat metabolism without binding the GH receptor or raising IGF-1.

AOD-9604 research reference

Reference figures summarized from published research literature for context only. These are not instructions, protocols, or dosing advice — AOD-9604 is a research compound for laboratory use, not for human consumption.

• Published research range: 250–500 mcg per dose, daily in published research design (research range)
• Administration (in research): Subcutaneous
• Storage & handling: Refrigerate after reconstitution; used within 30 days in most research protocols.

Get it & verify it

AOD-9604 sits at the center of a small content cluster on this site. Whether you are sourcing a vial, preparing one, or checking a Certificate of Analysis, start with the relevant guide below.

• Where to buy AOD-9604 — the 2026 buying guide: what to verify and how the tested vendors compared.
• AOD-9604 reconstitution calculator — compute concentration per insulin-syringe unit from your vial and BAC water.
• AOD-9604 COA guide — how to read a AOD-9604 Certificate of Analysis line by line.
• AOD-9604 research guide — deeper background on the compound and its research literature.

Sourcing AOD-9604 in 2026

The 2025–2026 vendor shakeout put the burden of verification on the buyer. Treat every AOD-9604 listing as unproven until it ships with a batch-specific Certificate of Analysis showing HPLC purity at or above 98% from a named third-party lab. In our 2026 blinded HPLC evaluation, ROEHN Research scored highest at 9.6/10 and was the only supplier where every tested sample met or exceeded its label claim — publishing a batch COA and shipping cold-chain by default. Peptide Research Review readers get 15% off a first order with code FREE15.

View AOD-9604 at ROEHN Research (code FREE15)→

Other metabolic & glp-1 compounds

Semaglutide · Tirzepatide · Retatrutide

AOD-9604 and all compounds referenced are for laboratory research use only — not for human consumption. Reference ranges are summarized from published research literature and are not medical, dosing, or therapeutic advice.